{"id":51137,"date":"2016-08-31T16:08:43","date_gmt":"2016-08-31T16:08:43","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=51137"},"modified":"2022-12-01T13:10:14","modified_gmt":"2022-12-01T18:10:14","slug":"drug-testing-industry-trainings","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/drug-testing-industry-trainings\/","title":{"rendered":"Drug Testing Industry Trainings"},"content":{"rendered":"\n<p>Visit our&nbsp;<a href=\"https:\/\/www.joereilly.com\/training-courses.html\" target=\"_blank\" rel=\"noopener noreferrer\">affiliated company Joe Reilly &amp; Associates, Inc<\/a> for all training for employers drug-free workplace program.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">DOT Collector Training<\/h2>\n\n\n\n<p>DOT regulations for the <strong>DOT drug and alcohol testing program<\/strong> require urine specimen collectors to be trained and qualified.&nbsp; Once you register and submit payment, you will receive a confirmation e-mail and instructions to log into the webinar. You will also receive required self-study pre-training materials to review on your own in advance of the webinar.&nbsp; Training for DOT specimen collections is <a href=\"https:\/\/www.nationaldrugscreening.com\/dot-drug-test\/\"><strong>required by the United States Department of Transportation (DOT).<\/strong><\/a>&nbsp; Our program is the most comprehensive in the industry for initial certification as a DOT collector.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">DESIGNATED EMPLOYER REPRESENTATIVE (DER) Training<\/h2>\n\n\n\n<p>The Designated Employer Representative, or DER, is an employee authorized to take immediate action to remove employees from (or have them removed from) safety-sensitive duties and to make required decisions in the testing and evaluation processes.&nbsp; The DER function cannot be outsourced.&nbsp; The position of DER is a huge responsibility for a company employee.&nbsp; Take advantage of this training for <a href=\"https:\/\/www.nationaldrugscreening.com\/dot-drug-test\/\"><strong>DOT regulated employers<\/strong><\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Supervisor Training &#8211; Reasonable Suspicion<\/h2>\n\n\n\n<p>Reasonable Suspicion Training Webinar for Supervisors &#8211; This course trains supervisors on how to recognize the signs, symptoms, and performance indicators of drug abuse and alcohol misuse.&nbsp; This is required training under DOT regulations for supervisors of safety-sensitive employees.&nbsp; Don\u2019t make a decision to perform reasonable suspicion drug testing without this training.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Visit our&nbsp;affiliated company Joe Reilly &amp; Associates, Inc for all training for employers drug-free workplace program. DOT Collector Training DOT regulations for the DOT drug and alcohol testing program require urine specimen collectors to be trained and qualified.&nbsp; Once you register and submit payment, you will receive a confirmation e-mail and instructions to log into [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":52621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51391,51535,50870,50935,50862,50901","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51137"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=51137"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/51137\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/52621"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=51137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=51137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=51137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}